Background illustration for clinical trials search

Paid Clinical Trials Iowa

Discover 667 paid clinical trials in Iowa. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Characterizing the Impact of Presbyphonia on Social Interaction

for
Presbyphonia
Location: Iowa City IA
Sponsor: Matthew R. Hoffman

Sex: All

Age: 65+

Code: NCT06441136

Recruiting

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

for
Cystic Fibrosis
Location: Boston MA, Valhalla NY, New York NY, Burlington VT,
Sponsor: Sonya Heltshe

Sex: All

Age: 0 - 10

Code: NCT04509050

Recruiting

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

for
Idiopathic Short Stature
Location: The Bronx NY, New York NY, Washington D.C. DC,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 3 - 11

Code: NCT06382155

Phase 2, Recruiting

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

for
Non-cystic Fibrosis Bronchiectasis
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Sex: All

Age: 18 - 70+

Code: NCT06559150

Phase 2, Recruiting

MMP-9 Inhibition for Recalcitrant Wet AMD

for
Exudative Macular Degeneration,
Location: Iowa City IA
Sponsor: University of Iowa

Sex: All

Age: 50 - 70+

Code: NCT04504123

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

for
Epilepsy, Temporal Lobe
Location: Syracuse NY, Charlottesville VA, Durham NC,
Sponsor: Neurona Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06422923

Phase 1, Phase 2, Recruiting

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

for
Growth Hormone Deficiency
Location: Manchester NH, Lebanon NH, New Hyde Park NY,
Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All

Age: 1 - 18

Code: NCT05775523

Recruiting

Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.

for
Recurrent Acute Pancreatitis
Location: Birmingham AL, Iowa City IA, Rochester MN
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 70+

Code: NCT06253117

Phase 2, Recruiting

The Effects of the CF Carrier State on the Kidneys and Pancreas

for
Carrier State, Pancreatic Disease, Kidney Diseases
Location: Iowa City IA
Sponsor: Philip Polgreen

Sex: All

Age: 18 - 70+

Code: NCT05474417

Recruiting

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

for
NSCLC, Stage I
Location: New Brunswick NJ, Hershey PA, Richmond VA,
Sponsor: Greg Durm, MD

Sex: All

Age: 18+

Code: NCT04317534

Phase 2, Recruiting

JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction

for
Patellar Dislocation, Recurrent, Patellar Dislocation,
Location: Boston MA, New York NY, Wake Forest NC, Gainesville FL,
Sponsor: Hospital for Special Surgery, New York

Sex: All

Age: 10 - 35

Code: NCT06883396

Recruiting

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

for
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma,
Location: The Bronx NY, New York NY, Hackensack NJ,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT05826535

Phase 1, Phase 2, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Boston MA, Lake Success NY, The Bronx NY, Brooklyn NY,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase 3, Recruiting

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

for
Breast Cancer, Solid Tumors, Adult
Location: Boston MA, New York NY, Fairfax VA, Tampa FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05768139

Phase 1, Phase 2, Recruiting

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

for
AL Amyloidosis
Location: Boston MA, Guilford CT, Hartford CT, North Haven CT,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06022939

Phase 3, Recruiting

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

for
Heart Diseases, Coronary Artery Disease,
Location: St. John's, Saint John, Providence RI, Hartford CT,
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 18+

Code: NCT04124120

Recruiting

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Boston MA, Quebec, New York NY, Bethesda MD,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT05006716

Phase 1, Phase 2, Recruiting

Hydrus® Microstent New Enrollment Post-Approval Study

for
Primary Open Angle Glaucoma
Location: Southern Pines NC, Fraser MI, Cincinnati OH, Kenosha WI,
Sponsor: Alcon Research

Sex: All

Age: 45+

Code: NCT04553523

Recruiting

Sex Differences in the Vascular Effects of E-cigarette Use

for
E-cigarette Use
Location: Iowa City IA
Sponsor: Anna Stanhewicz, PhD

Sex: All

Age: 18 - 24

Code: NCT06159608

Early Phase 1, Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Halifax, Boston MA, The Bronx NY, New York NY,
Sponsor: CG Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06567743

Phase 2, Recruiting

Popular cities in Iowa

Offering a distinguished healthcare infrastructure and top class research institutions, Iowa has emerged as a significant base for a wide range of clinical trials. Major institutions such as the University of Iowa Hospitals and Clinics and the Holden Comprehensive Cancer Center are at the forefront of these studies, driving advancements in fields like oncology, cardiovascular research, and more. Iowa’s commitment to medical innovation and its growing network of research centers make it a developing hub in cutting-edge clinical trials.

Why choose Iowa for clinical trials?

Iowa offers distinct advantages for those participating in clinical trials. The state's distinct population, combined with its strong agricultural and rural communities, provides a diverse range of participants that enhances the accuracy and applicability of research findings. Iowa is also recognized for its innovative research environment and its cutting-edge medical advancements, driven by leading institutions such as the University of Iowa.

By choosing to participate in a clinical trial in Iowa, participants contribute to critical medical research while benefiting from a well-established and supportive clinical research infrastructure that promotes breakthroughs in patient care and treatment.

Common conditions studied in Iowa

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Iowa